Organigram secures United Kingdom cannabis supply deal
Canadian licensed producer Organigram Holdings has struck a supply agreement with 4C Labs to provide dried medical cannabis flower for the United Kingdom market.
International Marijuana Business News – Europe
Canadian licensed producer Organigram Holdings has struck a supply agreement with 4C Labs to provide dried medical cannabis flower for the United Kingdom market.
Insurance reimbursements for medical cannabinoid products in Germany continued to grow in the first quarter of 2023, showing that Europe’s largest economy continues to see a gradual expansion of its cannabis industry – now one of the largest in the world.
Europe’s largest economy inched closer to ending marijuana prohibition after the German federal cabinet gave the green light to a watered-down bill to legalize some recreational cannabis use.
A significant jump in plant-propagation sales and medical marijuana exports helped Canadian licensed producer Aurora Cannabis narrow its loss in the first quarter of fiscal year 2024 to 28.3 million Canadian dollars ($20 million).
Germany’s cannabis ambitions could still be partially incompatible with European Union law, even though Berlin significantly scaled back the initiative, according to the country’s parliamentary research unit.
Are medical and adult-use cannabis effectively the same thing, and can businesses thrive in both markets?
Some executives and regulators will tell you there is no real difference, but Bedrocan founder Tjalling Erkelens isn’t one of them.
In the face of slumping cannabis stock prices, publicly traded Canadian marijuana producers and U.S. ancillary companies are increasingly turning to share consolidations to maintain their listings on the Nasdaq exchange.